Human DFNA5/GSDME ELISA Kit
Sensitivity
0.09 ng/mL
Range
0.47-30 ng/mL
Reactivity
Human
Cat no : KE00523
Synonyms
DFNA5, Gasdermin E, Gasdermin-E, GSDME, deafness, autosomal dominant 5
Validation Data Gallery
Product Information
KE00523 is a solid phase sandwich Enzyme Linked-Immuno-Sorbent Assay (Sandwich ELISA). The human DFNA5 ELISA kit is to be used to detect and quantify protein levels of endogenous human DFNA5. The assay recognizes human DFNA5. An antibody specific for human DFNA5 has been pre-coated onto the microwells. The human DFNA5 protein in samples is captured by the coated antibody after incubation. Following extensive washing, another horseradish peroxidase (HRP)-conjugated antibody specific for human DFNA5 is added to detect the captured human DFNA5 protein. For signal development, followed by Tetramethyl-benzidine (TMB) reagent. Solution containing sulfuric acid is used to stop color development and the color intensity which is proportional to the quantity of bound protein is measurable at 450 nm with the correction wavelength set at 630 nm.
| Product name | Human DFNA5/GSDME ELISA Kit |
| Tests | 1 X 96 well plate |
| Sample type | Cell lysate |
| Assay type | Sandwich |
| Sensitivity | 0.09 ng/mL |
| Range | 0.47-30 ng/mL |
| Reactivity | Human |
| Tested applications | Sandwich ELISA |
| Gene ID (NCBI) | 1687 |
Recovery
| Sample Type | Average | Range |
|---|---|---|
| Cell lysate | 99% | 90%-111% |
IntraAssay
| Sample | n | mean ( ng/mL) | SD | CV% |
|---|---|---|---|---|
| 1 | 8 | 13.42 | 0.48 | 3.59 |
| 2 | 8 | 3.25 | 0.11 | 3.49 |
| 3 | 8 | 1.74 | 0.06 | 3.34 |
InterAssay
| Sample | n | mean ( ng/mL) | SD | CV% |
|---|---|---|---|---|
| 1 | 16 | 13.54 | 0.45 | 3.32 |
| 2 | 16 | 3.29 | 0.13 | 3.82 |
| 3 | 16 | 1.71 | 0.06 | 3.54 |
Background Information
DFNA5 was first identified as a gene causing autosomal dominant hearing loss (HL). Different mutations have been found, all exerting a highly specific gain-of-function effect, in which skipping of exon 8 causes the HL. Later reports revealed the involvement of the gene in different types of cancer. Epigenetic silencing of DFNA5 in a large percentage of gastric, colorectal and breast tumors and p53-dependent transcriptional activity have been reported, concluding that DFNA5 acts as a tumor suppressor gene in different frequent types of cancer. Previous transfection studies with mutant DFNA5 in yeast and in mammalian cells showed a toxic effect of the mutant protein, which was not seen after transfection of the wild-type protein. DFNA5 is composed of two domains, separated by a hinge region. The first region induces apoptosis when transfected in HEK293T cells, the second region masks and probably regulates this apoptosis inducing capability. Moreover, the involvement of DFNA5 in apoptosis-related pathways in a physiological setting was demonstrated through gene expression microarray analysis using Dfna5 knockout mice.
Properties
| Storage Instructions | All the reagents are stored at 2-8℃ for 6 months or -20℃ for 12 months. Refer to the protocol for further storage instructions. |
| Synonyms | DFNA5, Gasdermin E, Gasdermin-E, GSDME, deafness, autosomal dominant 5 |